UA103490C2 - Composition of flavanolignan and amino acid with improved water solubility - Google Patents

Composition of flavanolignan and amino acid with improved water solubility

Info

Publication number
UA103490C2
UA103490C2 UAA201100594A UAA201100594A UA103490C2 UA 103490 C2 UA103490 C2 UA 103490C2 UA A201100594 A UAA201100594 A UA A201100594A UA A201100594 A UAA201100594 A UA A201100594A UA 103490 C2 UA103490 C2 UA 103490C2
Authority
UA
Ukraine
Prior art keywords
flavanolignan
composition
amino acid
water solubility
improved water
Prior art date
Application number
UAA201100594A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Милан Стухлик
Иржи Копенец
Original Assignee
Агра Групп, А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Агра Групп, А.С. filed Critical Агра Групп, А.С.
Publication of UA103490C2 publication Critical patent/UA103490C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

The invention relates to a composition containing flavanolignans, e.g., isolated from Silybum marianum, and basic amino acids and, optionally, other auxiliary substances, in the form of mixture, and to the method of preparation of these compositions by mixing the components and their homogenization. The invention is applicable particularly in the pharmaceutical industry, cosmetics, food industry, breweries, distilleries, and in the industry of beverage production. Formula (I)(I),
UAA201100594A 2008-06-26 2009-06-22 Composition of flavanolignan and amino acid with improved water solubility UA103490C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20080407A CZ300846B6 (en) 2008-06-26 2008-06-26 Water-soluble composition based on flavanonol lignanes and process for preparing thereof
PCT/CZ2009/000086 WO2009155887A1 (en) 2008-06-26 2009-06-22 Composition of flavanolignan and amino acid with improved water solubility

Publications (1)

Publication Number Publication Date
UA103490C2 true UA103490C2 (en) 2013-10-25

Family

ID=40986372

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201100594A UA103490C2 (en) 2008-06-26 2009-06-22 Composition of flavanolignan and amino acid with improved water solubility

Country Status (14)

Country Link
US (1) US8426459B2 (en)
EP (1) EP2307405B1 (en)
JP (1) JP2011525498A (en)
CN (1) CN102066364A (en)
AU (1) AU2009264469A1 (en)
BR (1) BRPI0914180A2 (en)
CA (1) CA2727197A1 (en)
CZ (1) CZ300846B6 (en)
EA (1) EA016903B1 (en)
MX (1) MX2010014466A (en)
PL (1) PL2307405T3 (en)
UA (1) UA103490C2 (en)
WO (1) WO2009155887A1 (en)
ZA (1) ZA201100265B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2008841A3 (en) * 2008-12-23 2010-07-28 Agra Group, A.S. Beer and beer-based beverages and method of adjusting content of polyphenols and silicon therein
UA97282C2 (en) * 2010-02-09 2012-01-25 Евгений Леонидович Юхниця Composition and process for the production of “radoi” beer
WO2016149685A1 (en) 2015-03-19 2016-09-22 Cydex Pharmaceuticals, Inc. Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
CZ308418B6 (en) * 2015-06-23 2020-08-12 Mendelova Univerzita V Brně, Zahradnická Fakulta,Ústav Posklizňové Technologie Zahradnických Produktů Beer or beer-based beverage containing lignans and method of producing it
TWI761672B (en) 2018-04-23 2022-04-21 日商阿爾卑斯藥品工業股份有限公司 Compositions of o-glycosyl flavonoids
JP7214247B2 (en) * 2018-06-09 2023-01-30 江▲蘇▼新元素医▲薬▼科技有限公司 COMPOUNDS FOR THE TREATMENT OR PREVENTION OF LIVER DISEASE
US10918654B1 (en) 2019-09-23 2021-02-16 Alps Pharmaceutical Ind. Co., Ltd. Rutin compositions
US11110109B2 (en) 2019-10-22 2021-09-07 Alps Pharmaceutical Ind. Co., Ltd. Water soluble O-glycosyl flavonoid compositions and methods for preparing same

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT332535B (en) * 1973-01-19 1976-10-11 Madaus & Co Dr PROCESS FOR THE PRODUCTION OF NEW WATER-SOLUBLE SALT OF THE ACTIVE SUBSTANCES OF THE SILYMARING GROUP
GB1554662A (en) * 1976-05-05 1979-10-24 Inverni Della Beffa Spa Polyhydroxyphenylchromanones
IT1215291B (en) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa FLAVANOLIGNANI COMPLEXES WITH PHOSPHOLIPIDS, THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
IT1222012B (en) * 1987-07-10 1990-08-31 Indena Spa PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING COMPLEX FLAVONOLIGNANS WITH PHOSPHOLIPIDS
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
IT1241673B (en) * 1989-10-09 1994-01-27 Istituto Biochimico Italiano INCLUSION COMPLEXES OF SILIBININ WITH CYCLODESTRINE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US5196448A (en) * 1991-01-22 1993-03-23 Stiefel Laboratories, Inc. Antiinflammatory compositions and method of use
GB2261434A (en) * 1991-11-15 1993-05-19 Inverni Della Beffa Spa New radical scavenging and antipoperoxidant flavanolignans their preparation and formulations for therapeutic use
DE4401902C2 (en) * 1994-01-24 2000-02-03 Madaus Ag Use of flavolignans as an adjuvant in tumor therapy
DE19501266A1 (en) 1995-01-18 1996-07-25 Madaus Ag Process for the preparation of flavano-lignan preparations with improved release and resorbability, preparations available thereafter and their use for the production of medicaments
IT1274549B (en) * 1995-05-23 1997-07-17 Indena Spa USE OF FLAVANOLIGNANI FOR THE PREPARATION OF MEDICATIONS FOR ANTI-PROLIFERATIVE ACTIVITY IN CANCER OF THE UTERUS, OVARIAN AND BREAST
CZ287657B6 (en) 1996-06-12 2001-01-17 Mikrobiologický Ústav Av Čr Silybinin glycosides and process of their preparation
WO1998000570A1 (en) * 1996-07-02 1998-01-08 The Timken Company Induction hardened microalloy steel having enhanced fatigue strength properties
JP3656972B2 (en) * 1997-02-14 2005-06-08 丸善製薬株式会社 Alcohol smell reducing agent
CZ292832B6 (en) 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Process for preparing silymarin exhibiting increased solubility
CN1397277A (en) * 2002-08-16 2003-02-19 广州瑞济生物技术有限公司 Process for preapring silymanium injection
US6913769B2 (en) * 2003-02-18 2005-07-05 Brian Douglas Oslick Compositions for prevention and treatment of symptoms associated with ethyl alcohol consumption
CN100402023C (en) * 2003-06-21 2008-07-16 山东绿叶天然药物研究开发有限公司 Legalon soft capsule and its preparing method
CN1490001A (en) * 2003-09-08 2004-04-21 南昌弘益科技有限公司 Hepadestal drops and preparation thereof
CN1666739A (en) * 2004-03-08 2005-09-14 山东绿叶天然药物研究开发有限公司 Application of Silibinin or its salts in preparation of medicine for treating coronary heart disease or strengthening the effect of coronary heart disease treatment
CN1247195C (en) * 2004-07-19 2006-03-29 北京科信必成医药科技发展有限公司 Silibinin oral disintegration tablet and its preparing method
US20060067959A1 (en) * 2004-09-28 2006-03-30 Marcel Nimni Compositions and methods for treatment of solar damage
CN100546577C (en) * 2004-11-22 2009-10-07 山东绿叶天然药物研究开发有限公司 The new medical use of silibinin or its salt
JP3914244B2 (en) * 2005-10-03 2007-05-16 株式会社ファンケル Abnormal protein removal composition
JP4954531B2 (en) * 2005-10-31 2012-06-20 一丸ファルコス株式会社 Peroxisome proliferator-responsive receptor activator
CA2645073A1 (en) * 2006-03-08 2007-09-13 Nuviance, Inc. Transdermal drug delivery compositions and topical compositions for application on the skin

Also Published As

Publication number Publication date
EA016903B1 (en) 2012-08-30
EA201100091A1 (en) 2011-06-30
EP2307405B1 (en) 2013-10-02
JP2011525498A (en) 2011-09-22
ZA201100265B (en) 2011-10-26
US20110207805A1 (en) 2011-08-25
MX2010014466A (en) 2011-04-28
WO2009155887A1 (en) 2009-12-30
US8426459B2 (en) 2013-04-23
CZ2008407A3 (en) 2009-08-26
PL2307405T3 (en) 2014-04-30
EP2307405A1 (en) 2011-04-13
CN102066364A (en) 2011-05-18
CA2727197A1 (en) 2009-12-30
BRPI0914180A2 (en) 2015-10-20
CZ300846B6 (en) 2009-08-26
AU2009264469A1 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
UA103490C2 (en) Composition of flavanolignan and amino acid with improved water solubility
WO2009147158A3 (en) Compositions of fat-soluble active ingredients containing gum ghatti
WO2007090610A3 (en) COMPOSITIONS CONTAINING ß-CAROTENE
EA201071167A1 (en) STABILIZED OLEOSOMIC COMPOSITIONS AND METHODS FOR THEIR PRODUCTION
EA201001555A1 (en) ANTIOXIDATIVE INFLAMMATION MODULATORS: DERIVATIVESIC DERIVATIVES WITH AMINUM AND OTHER MODIFICATIONS OF C-17
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
EA201190113A1 (en) CHOCOLATE COMPOSITIONS WITH IMPROVED STABILITY BASED ON RISK STARCH
WO2009057339A1 (en) Biodegradable composition, processed biodegradable article such as food container and method of producing the same
EA201290389A8 (en) APPLICATION OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES TO TREAT LIVER DISEASES
TW200745003A (en) Novel compounds
WO2010055082A3 (en) New crystal form of sunitinib malate
UA98804C2 (en) Catecholamine derivatives and pharmaceutical composition based thereon
TW200630336A (en) Novel compounds
TW200621690A (en) Novel compounds
DE502007006185D1 (en) SOLID ENYMFORMULATIONS AND PROCESS FOR THEIR PREPARATION
WO2011069629A3 (en) Pharmaceutical composition comprising oligopeptides, preferably cilengitide
TW200634007A (en) Substituted indoles, compositions containing them, production process and use
WO2011051968A3 (en) Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof
TW200718695A (en) Novel piperidine carboxylic acid amide derivatives
WO2011060297A3 (en) Oxygen scavengers, composition comprising the scavengers, and articles made from the compositions
EA201070606A1 (en) METHOD OF ACID CLEANING IN THE BREWING INDUSTRY
GEP20135733B (en) Novel diazeniumdiolate derivatives, their preparation method and pharmaceutical compositions containing them
TW200716664A (en) Immunoglobulin fraction and process therefor
GEP20125563B (en) 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same
NZ612454A (en) Phytotherapic pharmaceutical compositions, process of preparation of phytotherapic pharmaceutical composition and their veterinary uses